348 related articles for article (PubMed ID: 16839745)
1. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
2. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
[TBL] [Abstract][Full Text] [Related]
3. Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells.
An HJ; Cho NH; Yang HS; Kwak KB; Kim NK; Oh DY; Lee SW; Kim HO; Koh JJ
J Pathol; 2007 Jun; 212(2):161-9. PubMed ID: 17427168
[TBL] [Abstract][Full Text] [Related]
4. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
5. Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression.
Xia C; Meng Q; Cao Z; Shi X; Jiang BH
J Cell Physiol; 2006 Oct; 209(1):56-66. PubMed ID: 16775835
[TBL] [Abstract][Full Text] [Related]
6. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling.
Qian Y; Zhong X; Flynn DC; Zheng JZ; Qiao M; Wu C; Dedhar S; Shi X; Jiang BH
Oncogene; 2005 Apr; 24(19):3154-65. PubMed ID: 15735674
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
8. ANG II-stimulated DNA synthesis is mediated by ANG II receptor-dependent Ca(2+)/PKC as well as EGF receptor-dependent PI3K/Akt/mTOR/p70S6K1 signal pathways in mouse embryonic stem cells.
Han HJ; Han JY; Heo JS; Lee SH; Lee MY; Kim YH
J Cell Physiol; 2007 Jun; 211(3):618-29. PubMed ID: 17219409
[TBL] [Abstract][Full Text] [Related]
9. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
Zhong XS; Zheng JZ; Reed E; Jiang BH
Biochem Biophys Res Commun; 2004 Nov; 324(2):471-80. PubMed ID: 15474452
[TBL] [Abstract][Full Text] [Related]
10. EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway.
Chiu T; Santiskulvong C; Rozengurt E
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G182-94. PubMed ID: 15358595
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
Whitley BR; Beaulieu LM; Carter JC; Church FC
Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.
Noske A; Kaszubiak A; Weichert W; Sers C; Niesporek S; Koch I; Schaefer B; Sehouli J; Dietel M; Lage H; Denkert C
Cancer Lett; 2007 Feb; 246(1-2):190-200. PubMed ID: 16584837
[TBL] [Abstract][Full Text] [Related]
13. Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells.
Zhou HY; Wong AS
Endocrinology; 2006 May; 147(5):2557-66. PubMed ID: 16469801
[TBL] [Abstract][Full Text] [Related]
14. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.
Héron-Milhavet L; Franckhauser C; Rana V; Berthenet C; Fisher D; Hemmings BA; Fernandez A; Lamb NJ
Mol Cell Biol; 2006 Nov; 26(22):8267-80. PubMed ID: 16982699
[TBL] [Abstract][Full Text] [Related]
15. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
van Duijn PW; Trapman J
Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
[TBL] [Abstract][Full Text] [Related]
16. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549.
Sithanandam G; Fornwald LW; Fields J; Anderson LM
Oncogene; 2005 Mar; 24(11):1847-59. PubMed ID: 15688028
[TBL] [Abstract][Full Text] [Related]
18. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
[TBL] [Abstract][Full Text] [Related]
19. Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma.
Rychahou PG; Jackson LN; Silva SR; Rajaraman S; Evers BM
Ann Surg; 2006 Jun; 243(6):833-42; discussion 843-4. PubMed ID: 16772787
[TBL] [Abstract][Full Text] [Related]
20. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.
Chang F; Lee JT; Navolanic PM; Steelman LS; Shelton JG; Blalock WL; Franklin RA; McCubrey JA
Leukemia; 2003 Mar; 17(3):590-603. PubMed ID: 12646949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
